CN102072954A - Research and application of electrochemiluminescent immunosensor for detecting tumor markers - Google Patents

Research and application of electrochemiluminescent immunosensor for detecting tumor markers Download PDF

Info

Publication number
CN102072954A
CN102072954A CN2010105241970A CN201010524197A CN102072954A CN 102072954 A CN102072954 A CN 102072954A CN 2010105241970 A CN2010105241970 A CN 2010105241970A CN 201010524197 A CN201010524197 A CN 201010524197A CN 102072954 A CN102072954 A CN 102072954A
Authority
CN
China
Prior art keywords
electrode
immunosensor
tumor markers
preparation
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105241970A
Other languages
Chinese (zh)
Inventor
于京华
张萌
万夫伟
颜梅
葛慎光
藏德进
戴平
高伟强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinan University
University of Jinan
Original Assignee
University of Jinan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Jinan filed Critical University of Jinan
Priority to CN2010105241970A priority Critical patent/CN102072954A/en
Publication of CN102072954A publication Critical patent/CN102072954A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

The invention discloses a method for researching and applying an electrochemiluminescent immunosensor for detecting tumor markers. An electrode preparation method (shown in attached drawings as schematic diagrams) comprises the following steps of: selecting a tumor marker with higher clinical morbidity for detection; preparing a quantum dot nano-material solution; and preparing the electrochemiluminescent immunosensor by modifying an antibody onto an electrode surface by using an electrode surface modification technology. A method for detecting the tumor markers comprises the following step of connecting a modified electrode to an electrochemiluminescent instrument so as to detect a tumor marker in a sample. The electrode provided by the invention has strong specificity and high sensitivity and can reach ng level; and moreover, the time required for completing a basic detection process is short, and the cost is low. The method for detecting the tumor markers through the electrode has the advantages that: the operation is fast and simple, and both reactions and results are automatically completed and recorded by the instrument.

Description

Detect the research and the application of the electrochemiluminescimmunosensor immunosensor of tumor markers
Technical field
The present invention relates to tumor markers detection technique field, a kind of preparation that detects the electrochemiluminescimmunosensor immunosensor of tumor markers of more specifically saying so the invention still further relates to and adopts described electrochemiluminescimmunosensor immunosensor to carry out the method for diagnosing tumour mark.
Background technology
Tumour is the killer of human health.Malignant tumour also claims cancer, it is the class disease that current serious threatens human health and life, it be body be subjected to various in or external carcinogenic factor effect under, the cell of local organization has lost the normal regulation to himself growth on gene level, cause undesired hyperplasia and the neoformation that forms.Tumour be that long-term, multistage a, polygenes changes accumulation, have the complicacy of multifactor adjusting and controlled by multiple genes.The ascendant trend of tumor incidence and mortality ratio is directly threatening human health, and its early diagnosis and therapy is one of important preface field of treatment and prevention of tumour research.
Become in the growth course phenomenon that more and more has invasiveness of malignant tumour is called the evolution of tumour, its evolution process relate between the tumour cell and tumour and host between a series of complex interactions, the increment and the apoptosis that comprise tumour cell, the degraded of extracellular matrix, the change of tumour cell-cell, cell-matrix adhesion, the migration of cell, mobile, tumor-blood-vessel growth, escape host's immunosurveillance etc., these interact and mainly show the characteristics such as unlimited increment, aggressive and transfer of cell.In the growth of tumor process; because the subclone that can make tumour unusually of the sudden change of episome and coded product thereof obtains different characteristics, thereby the selection of body internal and external environment can make tumour keep in growth course should to survive, the subclone of growth, infiltration metastasis and can cause the generation of heterogeneousization of tumour.Therefore, strengthen to bring wide prospect for the treatment of tumor disease to the molecular basis of each link of tumour evolution and the understanding and the research of polygenes effect.
Immunoassay is to utilize antibody to combine with antigentic specificity and the high selectivity biochemical method set up.Detect and the peculiar tumor marker of positioning tumor cell with immunocytochemistry, more and more caused vast oncological pathology research worker's interest.There are many immunohistochemical methods to can be used for histiocytic qualitative and quantitative analysis and composition detection now.At present, main immune analysis method has electrochemical immunoanalytical, chemiluminescence immune assay, portable injection chemiluminescence immunoassay, high performance liquid chromatography chemiluminescence immune assay, capillary electrophoresis chemiluminescence immunoassay, fluidic chip chemiluminescence immunoassay etc.But be applied to the chemiluminescence immunoassay that mainly contains in the immunodiagnosis, electrochemical immunoanalytical method etc. are not enough but these detection methods exist:
1. chemiluminescence immunoassay has fast, the highly sensitive characteristics of finding speed, but the selectivity relative mistake some.Because types of organization's difference also can have one or more tumor markerses, therefore determine it is relatively difficulty of which kind of tumor disease with a kind of tumour by detected a certain specific tumors mark.
2. the electrochemical immunoanalytical method has characteristics easily and fast, and because current potential is controlled, has improved selectivity, can make diagnosis to different tumor markerses, and be applied to tumor treatment, but sensitivity is low relatively.
Based on the shortcoming of above-mentioned detection method, the present invention has set up a kind of high sensitivity, high selectivity, electrogenerated chemiluminescence immune analysis method easily and efficiently.
Summary of the invention
The technical problem to be solved in the present invention has provided that a kind of detection speed is fast, highly sensitive, selectivity is high, and reagent dosage is few, detects the preparation and the detection method of the electrochemiluminescimmunosensor immunosensor of tumor markers.
In order to solve the problems of the technologies described above, the present invention realizes by following measure: a kind of preparation method who detects the electrochemiluminescimmunosensor immunosensor of tumor markers is characterized in that may further comprise the steps:
(1) select clinical onset rate tumors of higher mark to measure;
(2) prepare the quantum dot nano material solution;
(3) utilize assembling surface modification technology etc., on the antibody modification electrode surface, make electrochemiluminescimmunosensor immunosensor.
Antibody modification of the present invention is measured to the immunosensor surface and to tumor markers and be may further comprise the steps:
(1) electrode used therein is used deionized water, acetone and ethanol ultrasonic cleaning respectively, used high-purity N afterwards 2Dry up;
(2) electrode that step (1) is obtained immerses 10-30min in the 4%NaOH solution, uses deionized water rinsing then, dry 1-2h under 120 ℃;
(3) specific antibody (Ab) is adsorbed onto the electrode surface of handling well, the not antibody of absorption is removed in washing behind 4 ℃ of incubation 12-24h, washs 2-5 time;
(4) electrode in the step (3) is added in the sample of determined antigen (Ag), 37 ℃ of incubation 1-2h wash 2-5 time;
(5) electrode in the step (4) is immersed in the specific antibody (AbE) of luminescence reagent mark, 37 ℃ of incubation 10-15min wash 2-5 time;
(6) will modify good electrode measures in conjunction with the electrogenerated chemiluminescence instrument.
The working electrode that uses of the present invention can be glassy carbon electrode, ITO electrode, gold electrode, platinum electrode.
Luminescence reagent of the present invention is trichlorine bipyridyl ruthenium and derivant, luminol and derivant thereof, acridinium ester class, lucigenin and quantum dot nano material.
Tumor markers of the present invention is alpha-fetoprotein (AFP), carcinomebryonic antigen, cancer embryo ferritin, pancreatic oncofetal antigen, cytokeratin, squama cancer associated antigen, prostate specific antigen (PSA), acid phosphatase (ACP), alkaline phosphatase (ALP), neuronspecific enolase (NSE), CEA, CA19-9, SCC, CA15-3, CA12-5, HCG, F-PSA, PAP, TMA, human chorionic gonadotrophin (hCG), Catecholamine matter.
A kind of method of fast detecting tumor markers is characterized in that comprising the steps: that the electrochemiluminescimmunosensor immunosensor that will make by above-mentioned any one method cooperates the electrogenerated chemiluminescence instrument, and tumor markers is detected.
Beneficial effect of the present invention:
1. the preparation method of tumor markers electrochemiluminescimmunosensor immunosensor, antibody modification is prepared electrochemiluminescimmunosensor immunosensor to electrode surface, adopt trichlorine bipyridyl ruthenium, luminol, acridinium ester, lucigenin and quantum dot nano material as luminescence reagent, make prepared tumor markers electrochemiluminescimmunosensor immunosensor have higher sensitivity and selectivity.
2. surface modification technology is applied in the middle of the preparation of electrochemiluminescimmunosensor immunosensor, make the preparation of tumor markers electrochemiluminescimmunosensor immunosensor of luminescence reagent synergy have controllability, improved the sensitivity and the accuracy of electrochemiluminescimmunosensor immunosensor.
3. the high specificity of electrochemiluminescimmunosensor immunosensor of the present invention since with antibody modification to electrode, and antigen carried out specific recognition, other non-specific molecules does not have influence to testing result in the sample; Highly sensitive, can reach the ng level; Reagent dosage is few, and detecting a sample only needs tens microlitre reagent; Cost is low.
4. electrochemiluminescimmunosensor immunosensor detects the method for tumor markers, highly sensitive, favorable reproducibility, electrode life is long, antijamming capability is strong, operation is simple fast, reaction and result finish and record automatically by instrument, avoided the influence of subjective factor, and guarantee that good repeatability is arranged, be convenient to on-the-spot the detection.
Description of drawings
Below in conjunction with the drawings and specific embodiments the present invention is done and to describe in further detail.
Accompanying drawing is the process synoptic diagram that antibody modification prepares electrochemiluminescimmunosensor immunosensor and tumor markers is detected to electrode surface.
Embodiment
A kind of electrochemiluminescimmunosensor immunosensor preparation method who detects tumor markers is characterized in that may further comprise the steps:
(1) select clinical onset rate tumors of higher mark to measure;
(2) prepare the quantum dot nano material solution;
(3) utilize assembling surface modification technology etc., on the antibody modification electrode surface, make electrochemiluminescimmunosensor immunosensor.
Antibody modification of the present invention is measured to the immunosensor surface and to tumor markers and be may further comprise the steps:
(1) electrode used therein is used deionized water, acetone and ethanol ultrasonic cleaning respectively, used high-purity N afterwards 2Dry up;
(2) electrode that step (1) is obtained immerses 10-30min in the 4%NaOH solution, uses deionized water rinsing then, dry 1-2h under 120 ℃;
(3) specific antibody (Ab) is adsorbed onto the electrode surface of handling well, the not antibody of absorption is removed in washing behind 4 ℃ of incubation 12-24h, washs 2-5 time;
(4) electrode in the step (3) is added in the sample of determined antigen (Ag), 37 ℃ of incubation 1-2h wash 2-5 time;
(5) electrode in the step (4) is immersed in the specific antibody (AbE) of luminescence reagent mark, 37 ℃ of incubation 10-15min wash 2-5 time;
(6) will modify good electrode measures in conjunction with the electrogenerated chemiluminescence instrument.
The working electrode that uses of the present invention can be glassy carbon electrode, ITO electrode, gold electrode, platinum electrode.
Luminescence reagent of the present invention is trichlorine bipyridyl ruthenium and derivant, luminol and derivant thereof, acridinium ester class, lucigenin and quantum dot nano material.
Tumor markers of the present invention is alpha-fetoprotein (AFP), carcinomebryonic antigen, cancer embryo ferritin, pancreatic oncofetal antigen, cytokeratin, squama cancer associated antigen, prostate specific antigen (PSA), acid phosphatase (ACP), alkaline phosphatase (ALP), neuronspecific enolase (NSE), CEA, CA19-9, SCC, CA15-3, CA12-5, HCG, F-PSA, PAP, TMA, human chorionic gonadotrophin (hCG), Catecholamine matter.
A kind of method of fast detecting tumor markers is characterized in that comprising the steps: that the electrochemiluminescimmunosensor immunosensor that will make by above-mentioned any one method cooperates the electrogenerated chemiluminescence instrument, and tumor markers is detected.
Embodiment 1 (the embryonal antigen class is as alpha-fetoprotein)
A kind of electrochemiluminescimmunosensor immunosensor preparation method who detects alpha-fetoprotein may further comprise the steps:
(1) select the higher alpha-fetoprotein of clinical onset to measure;
(2) utilize package technique, alpha-fetoprotein antibody is modified electrode surface, make electrochemiluminescimmunosensor immunosensor;
(3) working electrode is selected the ITO electrode for use, and electrode is used deionized water, acetone and ethanol ultrasonic cleaning respectively, uses high-purity N afterwards 2Dry up;
(4) electrode of handling well is immersed 10min in the 4%NaOH solution, use deionized water rinsing then, dry 2h under 120 ℃;
(5) CdTe quantum dot solution preparation: at N 2Under the protection, will now make NaHTe is the Te presoma, with CdCl 2Reaction under the condition of mercaptoacetic acid as stabilizing agent, makes water-soluble CdTe quantum dots solution;
(6) get the CdTe solution 20 μ l that prepare, ultrasonic 20min obtains homodisperse CdTe quantum dot solution;
(7) alpha-fetoprotein antibody is adsorbed onto the electrode surface of handling well, the not alpha-fetoprotein antibody of absorption is removed in washing behind 4 ℃ of incubation 24h, washs 3 times;
(8) electrode of handling well is added in the alpha-fetoprotein antigen samples, 37 ℃ of incubation 1h wash 3 times;
(9) the above-mentioned electrode of handling well is immersed in the quantum dot-labeled specificity alpha-fetoprotein antibody of CdTe, 37 ℃ of incubation 15min wash 3 times.
To make the alpha-fetoprotein electrochemiluminescimmunosensor immunosensor and cooperate the electrogenerated chemiluminescence instrument, the alpha-fetoprotein in human body, the animal blood serum sample will be detected, the results are shown in Table 1.Utilize existing method, preparation alpha-fetoprotein electrochemical immunosensor connects electrochemical workstation, and the alpha-fetoprotein in human body, the animal blood serum sample extracting solution is carried out actual detected, the results are shown in Table 1.
Table 1 alpha-fetoprotein electrochemiluminescimmunosensor immunosensor of the present invention and alpha-fetoprotein electrochemical immunosensor detect effect comparison
Figure BSA00000323637000041
The result as can be seen from table 1: the alpha-fetoprotein electrochemiluminescimmunosensor immunosensor has the wideer range of linearity, higher sensitivity and lower detectability than alpha-fetoprotein electrochemical immunosensor.
Embodiment 2 (the carbohydrate mark is as CA19-9)
A kind of electrochemiluminescimmunosensor immunosensor preparation method who detects CA 19-9 may further comprise the steps:
(1) select the higher CA19-9 of clinical onset to measure;
(2) utilize package technique, the CA19-9 antibody modification to electrode surface, is made electrochemiluminescimmunosensor immunosensor;
(3) working electrode is selected the ITO electrode for use, and electrode is used deionized water, acetone and ethanol ultrasonic cleaning respectively, uses high-purity N afterwards 2Dry up;
(4) electrode of handling well is immersed 10min in the 4%NaOH solution, use deionized water rinsing then, dry 1h under 120C;
(5) CdTe quantum dot solution preparation: at N 2Under the protection, will now make NaHTe is the Te presoma, with CdCl 2Reaction under the condition of mercaptoacetic acid as stabilizing agent, makes water-soluble CdTe quantum dots solution;
(6) get the CdTe solution 20 μ l that prepare, ultrasonic 20min obtains homodisperse CdTe quantum dot solution;
(7) CA19-9 antibody is adsorbed onto the electrode surface of handling well, the not CA19-9 antibody of absorption is removed in washing behind 4 ℃ of incubation 12h, washs 3 times;
(8) electrode of handling well is added in the CA19-9 antigen samples, 37 ℃ of incubation 1h wash 3 times;
(9) the above-mentioned electrode of handling well is immersed in the quantum dot-labeled CA19-9 antibody of CdTe, 37 ℃ of incubation 15min wash 3 times.
To make the CA19-9 electrochemiluminescimmunosensor immunosensor and cooperate the electrogenerated chemiluminescence instrument, the CA19-9 in human body, the animal blood serum sample will be detected, the results are shown in Table 2.Utilize existing method, preparation CA19-9 electrochemical immunosensor connects electrochemical workstation, and the CA19-9 in human body, the animal blood serum sample extracting solution is carried out actual detected, the results are shown in Table 2.
Table 2 CA19-9 electrochemiluminescimmunosensor immunosensor of the present invention and CA19-9 electrochemical immunosensor detect effect comparison
Figure BSA00000323637000051
The result as can be seen from table 2: the CA19-9 electrochemiluminescimmunosensor immunosensor has the wideer range of linearity, higher sensitivity and lower detectability than CA19-9 electrochemical immunosensor.
Embodiment 3 (protein-based) as cytokeratin
A kind of electrochemiluminescimmunosensor immunosensor preparation method who detects cytokeratin may further comprise the steps:
(1) select the higher cytokeratin of clinical onset to measure;
(2) utilize package technique, the cytokeratin antibody modification to electrode surface, is made electrochemiluminescimmunosensor immunosensor;
(3) working electrode is selected the ITO electrode for use, and electrode is used deionized water, acetone and ethanol ultrasonic cleaning respectively, uses high-purity N afterwards 2Dry up;
(4) electrode of handling well is immersed 10min in the 4%NaOH solution, use deionized water rinsing then, dry 2h under 120 ℃;
(5) CdTe quantum dot solution preparation: at N 2Under the protection, will now make NaHTe is the Te presoma, with CdCl 2Reaction under the condition of mercaptoacetic acid as stabilizing agent, makes water-soluble CdTe quantum dots solution;
(6) get the CdTe solution 20 μ l that prepare, ultrasonic 20min obtains homodisperse CdTe quantum dot solution;
(7) cytokeratin antibody is adsorbed onto the electrode surface of handling well, the not cytokeratin antibody of absorption is removed in washing behind 4 ℃ of incubation 20h, washs 4 times;
(8) electrode of handling well is added in the cytokeratin antigen samples, 37 ℃ of incubation 1h wash 4 times;
(9) the above-mentioned electrode of handling well is immersed in the quantum dot-labeled cytokeratin antibody of CdTe, 37 ℃ of incubation 15min wash 4 times.
To make the cytokeratin electrochemiluminescimmunosensor immunosensor and cooperate the electrogenerated chemiluminescence instrument, the cytokeratin in human body, the animal blood serum sample will be detected, the results are shown in Table 3.Utilize existing method, preparation cytokeratin electrochemical immunosensor connects electrochemical workstation, and the cytokeratin in human body, the animal blood serum sample extracting solution is carried out actual detected, the results are shown in Table 3.
Table 3 cytokeratin electrochemiluminescimmunosensor immunosensor of the present invention and cytokeratin electrochemical immunosensor detect effect comparison
Figure BSA00000323637000061
The result as can be seen from table 3: the cytokeratin electrochemiluminescimmunosensor immunosensor has the wideer range of linearity, higher sensitivity and lower detectability than cytokeratin electrochemical immunosensor.
Embodiment 4 (enzyme is as acid phosphatase)
A kind of electrochemiluminescimmunosensor immunosensor preparation method of detection of acidic phosphatase may further comprise the steps:
(1) select the higher acid phosphatase of clinical onset to measure;
(2) utilize package technique, the acid phosphatase antibody modification to electrode surface, is made electrochemiluminescimmunosensor immunosensor;
(3) working electrode is selected the ITO electrode for use, and electrode is used deionized water, acetone and ethanol ultrasonic cleaning respectively, uses high-purity N afterwards 2Dry up;
(4) electrode of handling well is immersed 10min in the 4%NaOH solution, use deionized water rinsing then, dry 2h under 120 ℃;
(5) CdTe quantum dot solution preparation: at N 2Under the protection, will now make NaHTe is the Te presoma, with CdCl 2Reaction under the condition of mercaptoacetic acid as stabilizing agent, makes water-soluble CdTe quantum dots solution;
(6) get the CdTe solution 20 μ l that prepare, ultrasonic 20min obtains homodisperse CdTe quantum dot solution;
(7) the acid phosphatase enzyme antibody is adsorbed onto the electrode surface of handling well, the not acid phosphatase enzyme antibody of absorption is removed in washing behind 4 ℃ of incubation 18h, washs 2 times;
(8) electrode of handling well is added in the acid phosphatase antigen samples, 37 ℃ of incubation 2h wash 2 times;
(9) the above-mentioned electrode of handling well is immersed in the quantum dot-labeled acid phosphatase enzyme antibody of CdTe, 37 ℃ of incubation 15min wash 2 times.
To make the acid phosphatase electrochemiluminescimmunosensor immunosensor and cooperate the electrogenerated chemiluminescence instrument, the acid phosphatase in human body, the animal blood serum sample will be detected, the results are shown in Table 4.Utilize existing method, preparation acid phosphatase electrochemical immunosensor connects electrochemical workstation, and the acid phosphatase in human body, the animal blood serum sample extracting solution is carried out actual detected, the results are shown in Table 4.
Table 4 acid phosphatase electrochemiluminescimmunosensor immunosensor of the present invention and acid phosphatase electrochemical immunosensor detect effect comparison
Figure BSA00000323637000071
The result as can be seen from table 4; The acid phosphatase electrochemiluminescimmunosensor immunosensor has the wideer range of linearity, higher sensitivity and lower detectability than acid phosphatase electrochemical immunosensor.
Embodiment 5 (steroids is as human chorionic gonadotrophin (hCG))
A kind of electrochemiluminescimmunosensor immunosensor preparation method who detects human chorionic gonadotrophin may further comprise the steps:
(1) select the higher human chorionic gonadotrophin of clinical onset to measure;
(2) utilize package technique, hCG antibodies is modified electrode surface, make electrochemiluminescimmunosensor immunosensor;
(3) working electrode selects the ITO electrode, and electrode is used deionized water, acetone and ethanol ultrasonic cleaning respectively, uses high-purity N afterwards 2Dry up;
(4) electrode of handling well is immersed 10min in the 4%NaOH solution, use deionized water rinsing then, dry 2h under 120 ℃;
(5) CdTe quantum dot solution preparation: at N 2Under the protection, will now make NaHTe is the Te presoma, with CdCl 2Reaction under the condition of mercaptoacetic acid as stabilizing agent, makes water-soluble CdTe quantum dots solution;
(6) get the CdTe solution 20 μ l that prepare, ultrasonic 20min obtains homodisperse CdTe quantum dot solution;
(7) hCG antibodies is adsorbed onto the electrode surface of handling well, the not hCG antibodies of absorption is removed in washing behind 4 ℃ of incubation 24h, washs 5 times;
(8) electrode of handling well is added in the human chorionic gonadotrophin antigen samples, 37 ℃ of incubation 2h wash 5 times;
(9) the above-mentioned electrode of handling well is immersed in the quantum dot-labeled hCG antibodies of CdTe, 37 ℃ of incubation 15min wash 5 times.
To make the human chorionic gonadotrophin electrochemiluminescimmunosensor immunosensor and cooperate the electrogenerated chemiluminescence instrument, the human chorionic gonadotrophin in human body, the animal blood serum sample will be detected, the results are shown in Table 5.Utilize existing method, preparation human chorionic gonadotrophin electrochemical immunosensor connects electrochemical workstation, and the human chorionic gonadotrophin in human body, the animal blood serum sample extracting solution is carried out actual detected, the results are shown in Table 4.
Table 5 inventor human chorionic gonadtropin electrochemiluminescimmunosensor immunosensor and human chorionic gonadotrophin electrochemical immunosensor detect effect comparison
Figure BSA00000323637000081
The result as can be seen from table 5: the human chorionic gonadotrophin electrochemiluminescimmunosensor immunosensor has the wideer range of linearity, higher sensitivity and lower detectability than human chorionic gonadotrophin electrochemical immunosensor.

Claims (6)

1. preparation method who detects the electrogenerated chemiluminescence sensor of tumor markers is characterized in that may further comprise the steps:
1.1 selecting clinical onset rate tumors of higher mark measures;
1.2 the nano material of utilization is prepared nano material according to existing method;
1.3 prepare quanta point material solution;
1.4 utilize assembling surface modification technology etc., on the antibody modification electrode surface, make electrochemiluminescimmunosensor immunosensor.
2. according to the described electrode preparation method of claim 1, it is characterized in that specific antibody modified the immunosensor electrode surface and tumor markers measured may further comprise the steps:
2.1 electrode used therein is used deionized water, acetone and ethanol ultrasonic cleaning respectively, uses high-purity N afterwards 2Dry up;
2.2 the electrode that step 2.1 is obtained immerses 10-30min in the 4%NaOH solution, uses deionized water rinsing then, dry 1-2h under 120 ℃;
2.3 (Ab) is adsorbed onto the electrode surface of handling well with specific antibody, the not antibody of absorption is removed in washing behind 4 ℃ of incubation 12-24h, washs 2-5 time;
2.4 the electrode in the step 2.3 is added in the sample of determined antigen (Ag), 37 ℃ of incubation 1-2h wash 2-5 time;
2.5 the electrode in the step 2.4 is immersed in the specific antibody (AbE) of luminescence reagent mark, 37 ℃ of incubation 10-15min wash 2-5 time;
2.6 will modify good electrode measures in conjunction with the electrogenerated chemiluminescence instrument.
3. according to the described electrode preparation method of claim 1, it is characterized in that the described working electrode that uses can be glassy carbon electrode, ITO electrode, gold electrode, platinum electrode.
4. according to the described electrode preparation method of claim 1, described luminescence reagent is trichlorine bipyridyl ruthenium and derivant, luminol and derivant thereof, acridinium ester class, lucigenin and quantum dot nano material.
5. electrode preparation method according to claim 4, described tumor markers are alpha-fetoprotein (AFP), carcinomebryonic antigen, cancer embryo ferritin, pancreatic oncofetal antigen, cytokeratin, squama cancer associated antigen, prostate specific antigen (PSA), acid phosphatase (ACP), alkaline phosphatase (ALP), neuronspecific enolase (NSE), CEA, CA19-9, SCC, CA15-3, CA12-5, HCG, F-PSA, PAP, TMA, human chorionic gonadotrophin (hCG), Catecholamine matter.
6. the method for a fast detecting tumor markers is characterized in that comprising following, step: will cooperate the electrogenerated chemiluminescence instrument by the electrochemiluminescimmunosensor immunosensor that above-mentioned any one method makes, tumor markers is detected.
CN2010105241970A 2010-10-29 2010-10-29 Research and application of electrochemiluminescent immunosensor for detecting tumor markers Pending CN102072954A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105241970A CN102072954A (en) 2010-10-29 2010-10-29 Research and application of electrochemiluminescent immunosensor for detecting tumor markers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105241970A CN102072954A (en) 2010-10-29 2010-10-29 Research and application of electrochemiluminescent immunosensor for detecting tumor markers

Publications (1)

Publication Number Publication Date
CN102072954A true CN102072954A (en) 2011-05-25

Family

ID=44031574

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105241970A Pending CN102072954A (en) 2010-10-29 2010-10-29 Research and application of electrochemiluminescent immunosensor for detecting tumor markers

Country Status (1)

Country Link
CN (1) CN102072954A (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102253194A (en) * 2011-06-25 2011-11-23 南方医科大学 Secondary antibody probe for sandwich immune reaction by using amperometric immunosensor
CN102435736A (en) * 2011-11-29 2012-05-02 桂林理工大学 Method for measuring antigen of ovarian cancer embryo by electrochemical luminescence (ECL) immunosensor
CN102749452A (en) * 2012-07-26 2012-10-24 山东大学 Near-infrared electro-generated chemiluminescence immunodetection method
CN102778561A (en) * 2012-07-26 2012-11-14 济南大学 Preparation and application of tumor marker immunosensor built by putamen nanometer materials
CN103116023A (en) * 2013-01-25 2013-05-22 宁波大学 ECL (electrochemiluminescence) immunosensor for detecting tumor markers and preparation method and applications thereof
CN103245656A (en) * 2013-04-25 2013-08-14 济南大学 Preparation and application of alpha fetoprotein and carcino-embryonic antigen electrochemiluminescence sensor
CN103884707A (en) * 2014-03-19 2014-06-25 南京医科大学 Luminol and trisruthenium-based potential-resolved electrochemiluminescence detection method and application thereof
CN104155445A (en) * 2014-07-14 2014-11-19 济南大学 Preparation and application of unmarked electrochemiluminescent tumor marker immunosensor
CN104297479A (en) * 2014-09-24 2015-01-21 济南大学 Preparation method and application of electrochemiluminescence immunoassay sensor for detecting tumor marker
CN104297464A (en) * 2014-09-06 2015-01-21 济南大学 Making method and application of mycotoxin photoelectrochemical sensor for in situ generation of CdS
CN104865240A (en) * 2015-05-29 2015-08-26 南京市第二医院 Disposable nanometer electrogenerated chemiluminescence two-component immune sensor and preparation method thereof
CN104865241A (en) * 2015-05-15 2015-08-26 济南大学 Method for preparing electrochemical luminescence cell sensor paper chips based on alloy nanoparticles modification
CN105452851A (en) * 2013-06-19 2016-03-30 豪夫迈·罗氏有限公司 Electrochemiluminescence method of detecting an analyte in a liquid sample and analysis system
CN106771147A (en) * 2016-12-22 2017-05-31 广州华弘生物科技有限公司 A kind of quick diagnosis platelet-activating factor acetylhydro-lase kit and its application method
CN104764737B (en) * 2015-04-08 2018-04-27 山东大学 A kind of monochromatic ECL immunologic detection methods based on green-light radiation quantum dot
CN109839501A (en) * 2019-01-30 2019-06-04 东南大学 A kind of electrochemiluminescimmunosensor immunosensor and the preparation method and application thereof measuring circulating tumor cell
CN110441295A (en) * 2019-08-26 2019-11-12 济南大学 One kind is based on ferritin encapsulation Ir (ppy)3Biosensor preparation method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1978587A (en) * 2005-12-02 2007-06-13 华中农业大学 Method for preparing small-particle-size water-soluble cadium selenide quantum dot and its use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1978587A (en) * 2005-12-02 2007-06-13 华中农业大学 Method for preparing small-particle-size water-soluble cadium selenide quantum dot and its use

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JING QIAN ET AL.: "Versatile immunosensor using a quantum dot coated silica nanosphere as a label for signal amplification.", 《ANAL CHEM》 *
XIAOYU LI ET AL.: "Electrochemiluminescence immunoassay at a nanoporous gold leaf electrode and using CdTe quantum dots labels.", 《MICROCHIM ACTA》 *
严枫,胡效亚: "免疫传感器在肿瘤标志物检测中的应用", 《分析测试学报》 *
卢业成等: "电化学发光免疫分析法在AFP定量检测中的应用", 《标记免疫分析与临床》 *
朱连德,朱果逸: "电化学发光传感器研究进展", 《分析科学学报》 *

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102253194A (en) * 2011-06-25 2011-11-23 南方医科大学 Secondary antibody probe for sandwich immune reaction by using amperometric immunosensor
CN102253194B (en) * 2011-06-25 2013-08-28 南方医科大学 Secondary antibody probe for sandwich immune reaction by using amperometric immunosensor
CN102435736A (en) * 2011-11-29 2012-05-02 桂林理工大学 Method for measuring antigen of ovarian cancer embryo by electrochemical luminescence (ECL) immunosensor
CN102778561B (en) * 2012-07-26 2013-11-13 济南大学 Preparation and application of tumor marker immunosensor built by putamen nanometer materials
CN102749452A (en) * 2012-07-26 2012-10-24 山东大学 Near-infrared electro-generated chemiluminescence immunodetection method
CN102778561A (en) * 2012-07-26 2012-11-14 济南大学 Preparation and application of tumor marker immunosensor built by putamen nanometer materials
CN102749452B (en) * 2012-07-26 2015-01-14 山东大学 Near-infrared electro-generated chemiluminescence immunodetection method
CN103116023B (en) * 2013-01-25 2015-04-15 宁波大学 ECL (electrochemiluminescence) immunosensor for detecting tumor markers and preparation method and applications thereof
CN103116023A (en) * 2013-01-25 2013-05-22 宁波大学 ECL (electrochemiluminescence) immunosensor for detecting tumor markers and preparation method and applications thereof
CN103245656A (en) * 2013-04-25 2013-08-14 济南大学 Preparation and application of alpha fetoprotein and carcino-embryonic antigen electrochemiluminescence sensor
CN103245656B (en) * 2013-04-25 2014-01-08 济南大学 Preparation and application of alpha fetoprotein and carcino-embryonic antigen electrochemiluminescence sensor
US11703504B2 (en) 2013-06-19 2023-07-18 Roche Diagnostics Operations, Inc. Electrochemiluminescence method of detecting an analyte in a liquid sample and analysis system
CN105452851A (en) * 2013-06-19 2016-03-30 豪夫迈·罗氏有限公司 Electrochemiluminescence method of detecting an analyte in a liquid sample and analysis system
CN103884707B (en) * 2014-03-19 2016-02-17 南京医科大学 A kind of electrochemiluminescence detection method based on luminol and bipyridyl ruthenium and application thereof
CN103884707A (en) * 2014-03-19 2014-06-25 南京医科大学 Luminol and trisruthenium-based potential-resolved electrochemiluminescence detection method and application thereof
CN104155445A (en) * 2014-07-14 2014-11-19 济南大学 Preparation and application of unmarked electrochemiluminescent tumor marker immunosensor
CN104297464A (en) * 2014-09-06 2015-01-21 济南大学 Making method and application of mycotoxin photoelectrochemical sensor for in situ generation of CdS
CN104297464B (en) * 2014-09-06 2016-04-20 济南大学 A kind of in-situ preparation CdS mycotoxin Optical Electro-Chemistry transducer production method and application
CN104297479A (en) * 2014-09-24 2015-01-21 济南大学 Preparation method and application of electrochemiluminescence immunoassay sensor for detecting tumor marker
CN104764737B (en) * 2015-04-08 2018-04-27 山东大学 A kind of monochromatic ECL immunologic detection methods based on green-light radiation quantum dot
CN104865241A (en) * 2015-05-15 2015-08-26 济南大学 Method for preparing electrochemical luminescence cell sensor paper chips based on alloy nanoparticles modification
CN104865241B (en) * 2015-05-15 2017-12-12 济南大学 A kind of preparation of the electroluminescent cell sensing paper chip of alloy nano particle modification
CN104865240B (en) * 2015-05-29 2019-11-19 南京市第二医院 Disposable nanometer electrogenerated chemiluminescence two-component immunosensor and preparation method thereof
CN104865240A (en) * 2015-05-29 2015-08-26 南京市第二医院 Disposable nanometer electrogenerated chemiluminescence two-component immune sensor and preparation method thereof
CN106771147A (en) * 2016-12-22 2017-05-31 广州华弘生物科技有限公司 A kind of quick diagnosis platelet-activating factor acetylhydro-lase kit and its application method
CN106771147B (en) * 2016-12-22 2018-06-05 广州华弘生物科技有限公司 A kind of quick diagnosis platelet-activating factor acetylhydro-lase kit and its application method
CN109839501A (en) * 2019-01-30 2019-06-04 东南大学 A kind of electrochemiluminescimmunosensor immunosensor and the preparation method and application thereof measuring circulating tumor cell
CN109839501B (en) * 2019-01-30 2022-04-08 东南大学 Electrochemiluminescence immunosensor for measuring circulating tumor cells and preparation method and application thereof
CN110441295A (en) * 2019-08-26 2019-11-12 济南大学 One kind is based on ferritin encapsulation Ir (ppy)3Biosensor preparation method
CN110441295B (en) * 2019-08-26 2021-10-26 济南大学 Ferritin-based packaging Ir (ppy)3Preparation method of biosensor

Similar Documents

Publication Publication Date Title
CN102072954A (en) Research and application of electrochemiluminescent immunosensor for detecting tumor markers
CN103116023B (en) ECL (electrochemiluminescence) immunosensor for detecting tumor markers and preparation method and applications thereof
Lin et al. A nanoparticle label/immunochromatographic electrochemical biosensor for rapid and sensitive detection of prostate-specific antigen
Wu et al. Biomedical and clinical applications of immunoassays and immunosensors for tumor markers
Wang et al. Quantum‐Dot‐based electrochemical immunoassay for high‐throughput screening of the prostate‐specific antigen
CN102967706B (en) Preparation method and application of flow injection chemiluminiscence immuno sensor for detecting tumor marker
CN104459132B (en) A kind of is preparation method and the application of the cancer of pancreas immunosensor of label based on golden electro-deposition and Au@Ag/CuO-GS
Li et al. Label-free sandwich imaging ellipsometry immunosensor for serological detection of procalcitonin
Chen et al. Detection of total and A1c-glycosylated hemoglobin in human whole blood using sandwich immunoassays on polydimethylsiloxane-based antibody microarrays
CN103018231A (en) Preparation method and application of composite nano material paper chip electrochemical luminescence immunosensor
CN104122309B (en) A kind of preparation of cyclodextrin-Cu@Ag electrochemical immunosensor
CN108982630A (en) A kind of preparation method and application of the electrochemical immunosensor of interlayer type detection prostate-specific antigen
Zhang et al. A smartphone-based rapid quantitative detection platform for lateral flow strip of human chorionic gonadotropin with optimized image algorithm
CN101021529A (en) High-flux detection system of multianalyte simultaneous detection and electrochemical immunoanalytical method
CN102226807B (en) Electrochemical immunoassay method based on Au-PB-SiO2 composite nano-particles
CN102914648A (en) Electrochemical immunosensor for detecting toxoplasma gondii IgM antibody and preparation method thereof
CN105241939A (en) Preparation method for immunosensor based on gold/silver core-shell magnetic graphene adsorption cadmium ion and application
CN104880456A (en) Preparation method and application of electrochemiluminescence immunosensor constructed on basis of GO/MWCNTs-COOH/Au @ CeO2
Shi et al. Joint enhancement strategy applied in ECL biosensor based on closed bipolar electrodes for the detection of PSA
CN105044083A (en) Method for preparing electrochemiluminescence immunosensor for alpha fetoprotein based on Au-g-C3N4 nanocomposite and application
CN102313814A (en) Nano-gold enhanced highly sensitive detection method for a plurality of lung cancer markers
Wang et al. Application of a microfluidic paper-based bioimmunosensor with laser-induced fluorescence detection in the determination of alpha-fetoprotein from serum of hepatopaths
Pan et al. Turn-on fluorescence measurement of acid phosphatase activity through an aggregation-induced emission of thiolate-protected gold nanoclusters
Shen et al. An electrochemical sandwich immunosensor based on signal amplification technique for the determination of alpha-fetoprotein
CN106066324A (en) A kind of preparation method and application of electroluminescent chemiluminescence biosensor label

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110525